|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation and amortization of property and equipment | |||||
| Amortization of acquired intangibles | |||||
| Amortization of capitalized contract costs | |||||
| Share-based compensation expense | |||||
| Provision for operating losses and credit losses | |||||
| Noncash lease expense | |||||
| Deferred income taxes | |||||
| Paid-in-kind interest capitalized to principal of notes receivable | |||||
| Equity in income of equity method investments, net of tax | |||||
| Facilities exit charges | |||||
| Distributions received on investments | |||||
| Impairment of goodwill | |||||
| Technology asset charge | |||||
| Net (gain) loss on business dispositions | |||||
| Other, net | |||||
| Changes in operating assets and liabilities, net of the effects of business combinations and dispositions: | |||||
| Accounts receivable | |||||
| Settlement processing assets and obligations, net | |||||
| Prepaid expenses and other assets | |||||
| Accounts payable and other liabilities | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Business combinations and other acquisitions, net of cash and restricted cash acquired | |||||
| Capital expenditures | |||||
| Issuance of notes receivable | |||||
| Payments received on notes receivable | |||||
| Net cash from sales of businesses | |||||
| Proceeds from sales of investments | |||||
| Other, net | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Changes in funds held for customers | |||||
| Changes in settlement processing assets and obligations, net | |||||
| Net (repayments) borrowings from settlement lines of credit | |||||
| Net (repayments) borrowings from commercial paper notes | |||||
| Proceeds from long-term debt | |||||
| Repayments of long-term debt | |||||
| Payments of debt issuance costs | |||||
| Repurchases of common stock | |||||
| Proceeds from stock issued under share-based compensation plans | |||||
| Common stock repurchased - share-based compensation plans | |||||
| Purchase of subsidiary shares from noncontrolling interest | |||||
| Distributions to noncontrolling interests | |||||
| Contributions from noncontrolling interests | |||||
| Payment of deferred and contingent consideration in business combination | |||||
| Purchase of capped calls related to issuance of convertible notes | |||||
| Dividends paid | |||||
| Net cash provided by (used in) financing activities | |||||
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | |||||
| Increase in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash, beginning of the period | |||||
| Cash, cash equivalents and restricted cash, end of the period | |||||
Loading...